Literature DB >> 20718792

Desmin-related myopathy.

K Y van Spaendonck-Zwarts1, L van Hessem, J D H Jongbloed, H E K de Walle, Y Capetanaki, A J van der Kooi, I M van Langen, M P van den Berg, J P van Tintelen.   

Abstract

Desmin-related myopathy (DRM) is an autosomally inherited skeletal and cardiac myopathy, mainly caused by dominant mutations in the desmin gene (DES). We provide (i) a literature review on DRM, including clinical manifestations, inheritance, molecular genetics, myopathology and management and (ii) a meta-analysis of reported DES mutation carriers, focusing on their clinical characteristics and potential genotype-phenotype correlations. Meta-analysis: DES mutation carriers (n = 159) with 40 different mutations were included. Neurological signs were present in 74% and cardiological signs in 74% of carriers (both neurological and cardiological signs in 49%, isolated neurological signs in 22%, and isolated cardiological signs in 22%). More than 70% of carriers exhibited myopathy or muscular weakness, with normal creatine kinase levels present in one third of them. Up to 50% of carriers had cardiomyopathy and around 60% had cardiac conduction disease or arrhythmias, with atrioventricular block as an important hallmark. Symptoms generally started during the 30s; a quarter of carriers died at a mean age of 49 years. Sudden cardiac death occurred in two patients with a pacemaker, suggesting a ventricular tachyarrhythmia as cause of death. The majority of DES mutations were missense mutations, mostly located in the 2B domain. Mutations in the 2B domain were predominant in patients with an isolated neurological phenotype, whereas head and tail domain mutations were predominant in patients with an isolated cardiological phenotype.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20718792     DOI: 10.1111/j.1399-0004.2010.01512.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  64 in total

Review 1.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 2.  Proteotoxicity and cardiac dysfunction.

Authors:  Patrick M McLendon; Jeffrey Robbins
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

Review 3.  Proteasome dysfunction in cardiomyopathies.

Authors:  Jennifer E Gilda; Aldrin V Gomes
Journal:  J Physiol       Date:  2017-03-16       Impact factor: 5.182

Review 4.  Evolving Approaches to Genetic Evaluation of Specific Cardiomyopathies.

Authors:  Loon Yee Louis Teo; Rocio T Moran; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2015-12

5.  The desmin coil 1B mutation K190A impairs nebulin Z-disc assembly and destabilizes actin thin filaments.

Authors:  Gloria M Conover; Carol C Gregorio
Journal:  J Cell Sci       Date:  2011-10-07       Impact factor: 5.285

6.  Cardiomyocyte-Specific Human Bcl2-Associated Anthanogene 3 P209L Expression Induces Mitochondrial Fragmentation, Bcl2-Associated Anthanogene 3 Haploinsufficiency, and Activates p38 Signaling.

Authors:  Megan T Quintana; Traci L Parry; Jun He; Cecelia C Yates; Tatiana N Sidorova; Katherine T Murray; James R Bain; Christopher B Newgard; Michael J Muehlbauer; Samuel C Eaton; Akinori Hishiya; Shin Takayama; Monte S Willis
Journal:  Am J Pathol       Date:  2016-06-17       Impact factor: 4.307

Review 7.  Desmin related disease: a matter of cell survival failure.

Authors:  Yassemi Capetanaki; Stamatis Papathanasiou; Antigoni Diokmetzidou; Giannis Vatsellas; Mary Tsikitis
Journal:  Curr Opin Cell Biol       Date:  2015-02-11       Impact factor: 8.382

8.  A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.

Authors:  Guan-Sheng Liu; Ana Morales; Elizabeth Vafiadaki; Chi Keung Lam; Wen-Feng Cai; Kobra Haghighi; George Adly; Ray E Hershberger; Evangelia G Kranias
Journal:  Cardiovasc Res       Date:  2015-04-07       Impact factor: 10.787

9.  Toward Personalized Medicine: Does Genetic Diagnosis of Pediatric Cardiomyopathy Influence Patient Management?

Authors:  Teresa M Lee; Stephanie M Ware
Journal:  Prog Pediatr Cardiol       Date:  2015-07-01

10.  Desmin and αB-crystallin interplay in the maintenance of mitochondrial homeostasis and cardiomyocyte survival.

Authors:  Antigoni Diokmetzidou; Elisavet Soumaka; Ismini Kloukina; Mary Tsikitis; Manousos Makridakis; Aimilia Varela; Constantinos H Davos; Spiros Georgopoulos; Vasiliki Anesti; Antonia Vlahou; Yassemi Capetanaki
Journal:  J Cell Sci       Date:  2016-08-26       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.